Stanrose Mafatlal Investment & Finance Ltd

Stanrose Mafatlal Investment & Finance Ltd recorded a modest weekly gain of 3.70% to close at Rs.70.00 on 13 February 2026, outperforming the Sensex which declined by 0.54% over the same period. The week was marked by significant volatility, with the stock surging 6.13% on 9 February before retreating midweek amid a downgrade to a strong sell rating. Despite mixed technical signals and weak fundamentals, the stock showed resilience in the face of broader market weakness.

As of December 4, 2025, Stanrose Mafat is considered overvalued with a negative PE ratio of -11.80 and an EV to EBITDA of -11.10, significantly underperforming compared to peers like Bajaj Finance and Life Insurance, and has also lagged behind the Sensex with a return of -10.13%.

On 21-Nov, Stanrose Mafatlal Investment & Finance Ltd witnessed a significant decline in its share price, closing at ₹65.31, down ₹5.64 or 7.95% from the previous close. This drop reflects a continuation of the stock’s underperformance relative to the broader market and its sector peers.

As of 18-Nov, Stanrose Mafatlal Investment & Finance Ltd is currently priced at Rs 70.95, reflecting a 5.72% increase today, but has a year-to-date decline of 11.86%. Despite outperforming its sector and the benchmark Sensex in the short term, the stock's longer-term performance remains weak.

As of 10-Nov, Stanrose Mafatlal Investment & Finance Ltd's stock price is Rs 67.07, down 3.91%, and has fallen 5.54% over the past week. The stock is underperforming compared to the Sensex, with significant drops in investor interest and trading below key moving averages.

Stanrose Mafat has experienced a significant decline in financial performance, with net sales dropping from 5.10 crore in March 2019 to 1.36 crore in March 2025, and consistent operating losses leading to a net profit loss of -2.26 crore in March 2025. Total assets decreased from 62.00 crore in March 2023 to 44.28 crore in March 2025, while cash flow from operating activities has remained stagnant.

As of 31-Oct, Stanrose Mafatlal Investment & Finance Ltd's stock price is Rs 72.87, up 2.63% today, but it has underperformed the Sensex year-to-date with a decline of 9.48%. Despite recent short-term gains, the stock faces volatility and reduced investor participation.

As of 29-Oct, Stanrose Mafatlal Investment & Finance Ltd's stock price is declining at Rs 68.17, down 6.39%, and has underperformed its sector significantly. Despite a 102% increase in delivery volume, the stock shows negative returns over various periods, contrasting with the overall market's upward trend.

As of 28-Oct, Stanrose Mafatlal Investment & Finance Ltd is currently priced at 73.00, reflecting a recent upward trend with a 5.32% total return over the last two days. Despite short-term gains, the stock has a year-to-date decline of 9.32%, indicating it has underperformed compared to the broader market.

As of October 23, 2025, Stanrose Mafat is considered undervalued with a low price-to-book ratio of 0.69 and a negative PE ratio of -14.41, indicating significant challenges compared to peers like Bajaj Finance and Life Insurance, despite a recent 2.85% weekly return, it has declined 10.68% year-to-date against the Sensex's 8.21% gain.

As of October 17, 2025, Stanrose Mafat is considered very expensive and overvalued, with a negative PE ratio of -13.63 and poor stock performance, significantly lagging behind peers like Bajaj Finance and Life Insurance.

As of October 17, 2025, Stanrose Mafat is considered very expensive and overvalued, with a PE ratio of -13.63 and significant underperformance compared to peers and the Sensex, indicating serious financial challenges.

As of October 17, 2025, Stanrose Mafat. is considered very expensive and overvalued due to a negative PE ratio of -13.63, an EV to EBITDA of -0.47, and a ROE of -5.31%, significantly underperforming its peers and the Sensex with a year-to-date return of -15.50%.